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Oligonucleotides Suppress IL-8 in Skin Keratinocytes
In Vitro and Offer Anti-Inflammatory Properties
In Vivo
Annette Dorn1,2,3,4, Ralf Joachim Ludwig1,4, Andreas Bock2, Diamant Thaci1, Katja Hardt1,
Ju¨rgen Bereiter-Hahn3, Roland Kaufmann1, August Bernd1 and Stefan Kippenberger1
DNA codes for genetic information. Furthermore, recent findings suggest that DNA offers additional function,
particularly in the recognition of microorganisms. In this study, we investigated two classes of oligodeoxy-
nucleotides (ODN) in skin keratinocytes; namely, an ODN comprising two cytidine-phosphate-guanosine (CpG)
motifs (CpG-1-phosphorothioate (PTO)) and a poly-cytidine (Non-CpG-5-PTO) as control. Both fluorescence-
tagged ODN were rapidly taken up by cells and accumulated already after 5 minutes in perinuclear
compartments. In order to test whether ODN convey immunological effects in keratinocytes, secretion of
IL-8 was measured. Interestingly, both CpG-1-PTO and Non-CpG-5-PTO suppressed basal and tumor necrosis
factor a-induced IL-8 levels measured in cell culture supernatants. Experiments using deletion mutant revealed a
critical length of approximately 16 nucleotides conveying IL-8 suppression. Studies regarding the ODN
backbone offered that PTO bondings are critical for significant IL-8 suppression. In order to substantiate the
anti-inflammatory response, a contact hypersensitivity mouse model was utilized. Topical application of Non-
CpG-5-PTO-containing ointments reduced ear thickness in sensitized mice. Taken together, these findings
suggest an anti-inflammatory effect of ODN in epithelial cells in vitro and in vivo, indicating that DNA molecules
offer distinct biological activities restricted to the physiological compartment applied. This effect seems to be
independent from Toll-like receptor 9.
Journal of Investigative Dermatology (2007) 127, 846–854. doi:10.1038/sj.jid.5700620; published online 30 November 2006
INTRODUCTION
In 1944, Avery et al. (1944) discovered DNA as the carrier of
genetic information. Besides this fundamental function, other
biological effects of this molecule have been identified. It was
Coley (1893, 1894) who found that a heat-inactivated extract
derived from streptococci – a preparation known as ‘‘Coley’s
toxin’’ – offered some immunological response in cancer
patients. It took almost 100 years to identify that bacterial
DNA itself conveyed this effect, as pre-incubation with
DNase – not RNase – abrogated the stimulation of the
immune system (Tokunaga et al., 1984). Consecutive studies
found a sequence-specific immunostimulatory effect. In
particular, oligodeoxynucleotides (ODN) with a central
palindrome sequence displaying an unmethylated cytidine-
phosphate-guanosine (CpG) motif were biologically active
(Krieg et al., 1995). Mammalian DNA shows a much lower
incidence of CpG dinucleotides than predicted by random
base utilization, whereas bacterial DNA has the expected
distribution (Bird, 1987; Hergersberg, 1991). Additionally,
the cytidine residue is about 60–90% methylated in
mammalian DNA (Bird, 1985). This makes the unmethylated
CpG motif a molecular pattern allowing the mammalian
immune system to distinguish between microbial and innate
DNA.
The recognition of so-called pathogen-associated mole-
cular patterns is mediated through a series of germ line
encoded receptors named pattern recognition receptors
(reviewed by Pasare and Medzhitov, 2003). Based on findings
in Drosophila, a new class of pattern recognition receptors
was identified in mammals recognizing a broad spectrum of
different microbial products. These receptors show high
homology to the Drosophila Toll-protein and are now known
as Toll-like receptors (TLRs) (Medzhitov et al., 1997). Among
the 11 already identified members with a specific pathogen-
associated molecular pattern ligand, TLR-9 shows binding of
unmethylated CpG-DNA in the endosomal compartment
(Tonkinson and Stein, 1994; Hemmi et al., 2000). The
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cytoplasmic domain of TLR-9 consists of the classical Toll/
IL-1 receptor-domain that interacts with the Toll/IL-1 receptor
domain of the adapter protein named myeloid differentiation
factor 88 (MyD88) (Schnare et al., 2000; Janeway and
Medzhitov, 2002). This assembly induces activation of the
IL-1 receptor-associated kinase (Suzuki et al., 2002) and the
tumor necrosis factor (TNF) receptor-associated factor 6. The
latter interacts with the cytoplasmic tail of CD40 (Ishida et al.,
1996), leading to activation of NF-kB and consecutively to
the expression of pro-inflammatory cytokines, such as TNFa,
IL-6, IL-1b, IL-12p40 (Yamamoto et al., 2004), and IL-8
(Jo´zsef et al., 2006) in immune cells.
Recently, it was found that also human keratinocytes
express TLR-9 indicating that the CpG motif conveys relevant
information in the skin organ (Mempel et al., 2003; Miller
et al., 2005). Of note, new data suggest that immunostimula-
tion is not only induced by CpG-ODN but also by ODN
lacking this motif (Vollmer et al., 2004). In this study, it was
tested whether the stimulatory effect of ODN known from
immune cells also applies to human skin keratinocytes. Here,
we show a length-dependent suppression of IL-8 by both,
CpG- and Non-CpG-ODN. The anti-inflammatory effect was
corroborated by a contact dermatitis mouse model.
RESULTS
ODN with and without CpG motifs cause IL-8 suppression
in vitro
Incubation of HaCaT cells with the 20-mer CpG-1-phosphoro-
thioate (PTO) for 18 hours led to suppression of secreted IL-8
(Figure 1). Basal levels of IL-8 as well as induced levels (by
treatment with 20 ng/ml TNFa) were reduced by CpG-1-PTO
in a concentration-dependent manner. Surprisingly, also
Non-CpG-5-PTO, an ODN devoid of CpG-motifs offered
suppression of IL-8 (Figure 1a). In order to evaluate if
ODN lengths is critical for IL-8 suppression, deletion muta-
tions of CpG-1-PTO and Non-CpG-5-PTO were tested. Figure
1b and c show that sequential deletion of ODN led to a
decrease of IL-8 suppression. A critical length of approxi-
mately 16 nucleotides was identified to be necessary for
significant IL-8 suppression in both ODN tested. In addition
to HaCaT cells, also normal human keratinocytes were
treated with different concentrations of CpG-1-PTO. Figure
1d shows a concentration-dependent IL-8 suppression by
CpG-1-PTO. In order to test if 6-mers (Non-CpG-5G-PTO and
CpG-9-PTO) that offer no IL-8 suppression, compete for the
same binding site of a putative receptor as their 20-mer
analogs, both ODN were given in parallel (Figure 2a and b). It
was found that IL-8 suppression by 2mM Non-CpG-5-PTO or
CpG-1-PTO was not interfered by increasing concentrations
(1–16mM) of Non-CpG-5G-PTO or CpG-9-PTO, indicating
that short ineffective sequences do not compete for the
same receptor-binding site as their longer and IL-8-suppressive
analogs.
In the following, it was analyzed whether the ODN
backbone has impact on IL-8 suppression (Figure 2c). CpG-1-
ODN was synthesized utilizing either phosphodiester (PDE)
or PTO backbone bondings. We show that CpG-1-ODN
solely consisting of phosphodiester bondings had only a margi-
nal effect on IL-8 suppression at concentrations ranging from 1
to 6 mM compared to CpG-1-ODN with phosphorothioate
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Figure 1. Oligonucleotides with and without CpG motif cause basal and TNFa-induced IL-8 suppression. (a) HaCaT keratinocytes were incubated for 18 hours
with CpG-1-PTO or Non-CpG-5-PTO with indicated concentrations in the absence or presence of 20 ng/ml TNFa. Cell-free supernatants were used for IL-8
detection. Both, CpG-1-PTO with two classical CpG motifs as well as Non-CpG-5-PTO cause concentration-dependent suppression of basal and TNFa-induced
IL-8 levels. Deletion mutants of (b) Non-CpG-5-PTO (2 and 4 mM) and (c) CpG-1-PTO (4 mM) show a length-dependent IL-8 suppression. (d) Normal human
keratinocytes were incubated for 18 hours with CpG-1-PTO. A concentration-dependent suppression of basal IL-8 levels is observed. Each bar represents the
mean of four independent experiments. The standard deviations are indicated. The experiment was repeated with similar results. *Po0.1, **Po0.01 compared
to controls without ODN treatment.
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backbone. This indicates that the molecule’s half-life is
important for its biological efficacy.
CpG methylation and transfection with TLR-9-DN or
MyD88-DN offer no effect on IL-8 suppression. Quantitative
real-time PCR shows no transcriptional regulation of IL-8
Other studies have shown that cytosine methylation of the
CpG motif abolished the immune stimulatory effect (Krieg,
2002). In order to test if IL-8 suppression by CpG-1-PTO is
sensitive against cytosine methylation, CpG-1-PTO was
hybridized with its reverse strand (CpG-1-PTO reverse) and
enzymatically methylated as described (Figure 3a). Surpris-
ingly, we found that both, unmethylated and methylated
double-stranded molecules, suppressed the basal level of IL-8
to the same extent. Furthermore, the role of TLR-9 – the
receptor of unmethylated CpG-ODN – was investigated
(Figure 3b). HaCaT cells expressing dominant-negative
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Figure 2. 6-mers do not interfere with IL-8 suppression by CpG-1-PTO and
Non-CpG-5-PTO. Backbone-modification modifies IL-8 suppressive effect.
HaCaT cells were incubated for 18 hours with (a) 2 mM Non-CpG-5-PTO or
(b) 2mM CpG-1-PTO together with respective ineffective analogs
(Non-CpG-5G-PTO and CpG-9-PTO) at the indicated concentrations.
Cell-free supernatants were used for IL-8 measurement. Non-CpG-5-PTO-
and CpG-1-PTO-mediated IL-8 suppression is not sensitive towards the
presence of ineffective derivates. (c) HaCaT cells were incubated for 18 hours
with CpG-1-ODN bearing different backbone modifications at the indicated
concentrations. Cell-free supernatants were used for IL-8 measurement.
CpG-1-ODN with phosphodiester (PDE) bondings shows only marginal
IL-8 suppression compared to CpG-1-PTO. Each bar represents the mean
of four independent experiments. The standard deviations are indicated. The
experiment was repeated with similar results. *Po0.05, **Po0.01 compared
to controls without ODN treatment.
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Figure 3. TLR-9 does not convey suppression of IL-8 by CpG-1-PTO and
Non-CpG-5-PTO. No transcriptional regulation of IL-8. (a) HaCaT cells were
incubated for 18 hours with 2 mM CpG-1-PTO forward, reverse, double-
stranded (ds), and methylated double-stranded CpG-1-PTO (ds-meth). Cell-
free supernatants were used for IL-8 measurement. Unmethylated as well
as methylated CpG-1-PTO show similar IL-8 suppression. (b) HaCaT cells
transiently transfected with TLR-9-DN and MyD88-DN, respectively, were
incubated for 18 hours with 4 mM CpG-1-PTO or Non-CpG-5-PTO. The empty
pcDNA-3 vector served as control. Cell-free supernatants were used for IL-8
measurement. Transfected cells show increased levels of basal IL-8, indicating
increased cell stress induced by transfection. Transfection efficacy was tested
by Western blot analysis using antibodies against TLR-9 and Flag-tag (MyD88)
(data not shown). Ectopic expression TLR-9-DN or MyD88-DN show no effect
on IL-8 suppression by CpG-1-PTO and Non-CpG-5-PTO. (c) HaCaT cells
were incubated with 4 mM CpG-1-PTO or Non-CpG-5-PTO for 10 hours
(bar¼ 1–3) or additionally treated with TNFa (50 ng/ml) for the last 6 hours
(bar¼ 5–6). Total cellular RNA was extracted, transcribed to cDNA, and
analyzed for IL-8 expression using quantitative real-time PCR. Values from
control cells were set to 1.0. Both ODN tested fail to regulate IL-8 expression
on the transcriptional level. Each bar represents the mean of three
independent experiments. The standard deviations are indicated. The
experiment was repeated with similar results. *Po0.05 compared to controls
without ODN treatment.
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TLR-9 (TLR-9-DN) or the dominant-negative adaptor protein
MyD88 (MyD88-DN) showed similar IL-8 suppression in
response to CpG-1-PTO and Non-CpG-5-PTO as cells
transfected with a control plasmid (pcDNA-3). All transfected
cells, independent of the plasmid-transfected, showed
increased basal levels of IL-8, indicating a general stress
response caused by the transfection. Transfection efficacy
was controlled by Western blot analysis using anti-TLR-9 and
anti-Flag (MyD88) (data not shown). These findings indicate
that IL-8 suppression by CpG-1-PTO and Non-CpG-5-PTO is
independent of the TLR-9 signaling pathway. To analyze if
IL-8 is regulated on the transcriptional level, quantitative
real-time PCR was performed. Figure 3c shows no regulation
of IL-8 messenger RNA by CpG-1-PTO or Non-CpG-5-PTO,
suggesting a post-transcriptional regulation of IL-8 by ODN.
Effects of ODN on DNA synthesis and LDH release
It was tested whether treatment with ODN has impact on
basic cellular parameters such as DNA synthesis and
membrane integrity in HaCaT keratinocytes. DNA synthesis
was not significantly influenced by CpG-1-PTO and CpG-9-
PTO after 18 hours, whereas treatment with Non-CpG-5-PTO
and Non-CpG-5G-PTO offered a slight suppression (Figure
4a). Furthermore, lactate dehydrogenase (LDH) release as a
marker for membrane integrity was measured. Treatment
with CpG-1-PTO, CpG-9-PTO, Non-CpG-5-PTO, or Non-
CpG-5G-PTO for 18 hours showed no effect on LDH release
(Figure 4b).
ODN uptake and trafficking
It is described that ODN-containing CpG motifs enter
immune cells via endocytosis and bind to TLR-9 in the
endosomal compartment (Dalpke et al., 2002). Here, we
studied trafficking of ODN with or without CpG motif in
HaCaT keratinocytes by using 50-Cy3-labeled CpG-1-PTO,
CpG-9-PTO, Non-CpG-5-PTO, and Non-CpG-5G-PTO. After
pulsing for 1 minute, cells were washed with phosphate-
buffered saline and incubated with fresh media for 5, 10,
60 minutes and 18 hours. Then, cells were fixed and
microscopically examined. For a better definition of cellular
localization, nuclei were stained with SytoxGreen as afore-
mentioned (Figure 5). Both 20-mers (CpG-1-PTO and Non-
CpG-5-PTO) offered a similar uptake kinetic: already after
5 minutes, both ODN entered the cells and accumulated in
perinuclear clusters (arrows) which were detectable for at
least 18 hours. The nuclei seemed to be basically free of CpG-
1-PTO and Non-CpG-5-PTO. In contrast, the 6-mers (CpG-9-
PTO and Non-CpG-5G-PTO) accumulated rapidly in the
nuclei and nucleoli (arrows). The signal of Non-CpG-5G-PTO
remained in the nucleoli for at least 18 hours; a weak signal
was also detectable in the cytoplasm (arrow). In contrast,
CpG-9-PTO was not detectable after 18 hours suggesting an
accelerated degradation.
Non-CpG-5-PTO protects from development of a cutaneous
delayed-type hypersensitivity response in vivo
Cutaneous inflammation is accompanied with increased
levels of IL-8 (Harvima et al., 1994; Gillitzer and Goebeler,
2001). Vice versa, blocking of IL-8 leads to a decrease in a
cutaneous delayed-type hypersensitivity response caused by
tuberculin (Larsen et al., 1995). As CpG-1-PTO and Non-
CpG-5-PTO treatment showed efficient suppression of IL-8
in vitro, topical application of CpG-1-PTO- or Non-CpG-5-
PTO-containing ointments were tested to protect against a
delayed-type hypersensitivity response in DNFB-sensitized
individuals. Twenty-four hours after re-exposition ear swel-
ling responses were evaluated (Figure 6a). In contrast to DAC
base cream-treated mice, ear swelling response was reduced
by Dermatops (prednicarbat), a glucocorticoid-containing
ointment with clinically established anti-inflammatory effect.
Also, Non-CpG-5-PTO reduced ear swelling response in
DNFB-sensitized mice whereas CpG-1-PTO-containing oint-
ment offered only a non-significant trend, reflecting the more
pronounced effect of Non-CpG-5-PTO in keratinocytes (see
also Figure 1a). Histological analyses corroborated the ear
swelling data measured (Figure 6b). Ears treated with base
cream showed a massive dermal edema compared to
Dermatops-treated ears. Likewise, ears treated with Non-
CpG-5-PTO showed a reduced dermal edema similar to
Dermatops-treated ears, whereas in CpG-1-PTO-treated ears
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Figure 4. ODN offer sequence-specific effects on 5-bromodeoxyuridine
incorporation but offer no effect on LDH release. HaCaT cells were
incubated with 2 and 4 mM CpG-1-PTO, CpG-9-PTO, Non-CpG-5-PTO, or
Non-CpG-5G-PTO for 18 hours. 5-Bromodeoxyuridine incorporation and
LDH release were detected as described under ‘‘Materials and Methods’’.
(a) The 20-mer CpG-1-PTO and its 6-mer derivative CpG-9-PTO offer no
effect on DNA synthesis. Non-CpG-5-PTO and Non-CpG-5G-PTO show a
slight suppression of DNA synthesis. (b) The four tested ODN (CpG-1-PTO,
CpG-9-PTO, Non-CpG-5-PTO, and Non-CpG-5G-PTO) have no significant
effect on LDH liberalization. Each bar represents the mean of eight
independent experiments. The standard deviations are indicated. The
experiment was repeated with similar results. *Po0.05 compared to
untreated cells.
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the dermal edema was comparable to ears treated with base
cream. Further immunohistochemical examination shows that
the majority of infiltrating cells were neutrophils (Figure 6c).
Neutrophils were frequently observed in base cream- and
CpG-1-PTO-treated ears. This was much less pronounced in
ears treated with Dermatops and Non-CpG-5-PTO.
The penetration of CpG-1-PTO and Non-CpG-5-PTO into
mouse skin was detected by using topically applied
fluorescent-labeled ODN. Figure 6d shows that already after
2 hours both ODN were within the epidermis as well as in the
supra-epidermal tissue.
DISCUSSION
CpG-ODN are reported to cause immune stimulatory effects
accompanied with the release of inflammatory cytokines in
immune cells (Bird, 1987; Hergersberg, 1991). Of note,
recent studies showed that ODN lacking this motif are also
able to activate the immune system (Vollmer et al., 2004).
Surprisingly, we demonstrate in this study a suppression of
IL-8, an inflammatory chemokine, in human keratinocytes
by CpG- and Non-CpG-ODN. Using deletion mutants, a
critical length of approximately 16 nucleotides was deter-
mined conveying significant IL-8 suppression. Our data also
show that suppression of IL-8 by CpG-ODN and Non-CpG-
ODN was not interfered by non-effective 6-mers, indicating
that these sequences do not compete for the same receptor-
binding site. Furthermore, it was found that a phos-
phorothioate backbone amplifies the efficiency of IL-8
suppression. This may be owing to a more efficient protection
against degradation by nucleases increasing the ODN half-
life (Ferreiro, 2003).
Epigenetic modifications such as methylation of cytosine
residues are known to modulate TLR-9-mediated effects of
CpG-ODN in immune cells (Krieg et al., 1995). This seems to
be an evolutionary conserved mechanism allowing the host
to distinguish between innate and – the less methylated –
bacterial DNA (Heeg et al., 1998; Hallman et al., 2001;
Krieg, 2002). The data presented show no difference between
methylated and non-methylated CpG motifs pointing to a
non-TLR-9-mediated mechanism conveying IL-8 suppression
in keratinocytes. This assumption was further corroborated by
transfection experiments using dominant-negative expression
plasmids of TLR-9 and adapter protein MyD88 that both
failed to block ODN-mediated IL-8 suppression. Data
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Figure 5. Cellular trafficking of ODN is length dependent. HaCaT cells were pulsed with 1mM of Cy3-labeled ODN for 1 minute and then incubated for
the indicated time interval in medium without ODN. Nucleus staining was performed with SytoxGreen as described in ‘‘Materials and Methods’’. The 20-mers
Non-CpG-5-PTO and CpG-1-PTO enter already after 5 minutes the cells and accumulate in perinuclear clusters (arrows). These signals maintain stable
for at least 18 hours. The nucleus is basically free of fluorescence. The 6-mers Non-CpG-5G-PTO and CpG-9-PTO translocate rapidly into the nuclei and
nucleoli (arrows). Photographs are representative of four parallel experiments. Bar¼ 10 mm.
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derived from quantitative real-time PCR showed no regula-
tion of IL-8 on the messenger RNA level, suggesting a
post-transcriptional regulation of IL-8 by ODN.
The exact cellular trafficking of ODN is still under debate,
but it is assumed that naked ODN with a length of 22
nucleotides are able to pass the cell membrane in a cell type-
specific manner (Shi and Hoekstra, 2004). Ha¨cker et al.
(1998) demonstrated in J774 macrophage cells that CpG- and
Non-CpG-ODN were both taken up by non-specific en-
docytosis. Tonkinson and Stein (1994) and Shi and Hoekstra
(2004) reported that in a second step, acidic vesicles transport
ODN to the cytosol and from there into the nucleus. The
acidification was shown to be necessary for the biological
activity of CpG-ODN (Ha¨cker et al., 1998). In this study using
HaCaT keratinocytes, ODN of different lengths showed
differential cellular trafficking. Both 20-mer ODN, CpG-1-
PTO, and Non-CpG-5-PTO enter rapidly the cells and
accumulate in perinuclear clusters as described by others
(Ha¨cker et al., 1998; Shi and Hoekstra, 2004). Furthermore,
we demonstrate that nuclear accumulation is extraordinary
facilitated for short sequences such as CpG-9-PTO and
Non-CpG-5G-PTO. However, as these ODN have no effect
on IL-8 suppression, an extended retention period in the
endosomes seems to amplify the biological effect in our
model.
To address the issue if the in vitro finding also applies to
the in vivo situation, a contact hypersensitivity mouse model
was utilized. Confirming the in vitro results, topically applied
preparations containing 1.4% Non-CpG-5-PTO alleviated the
intensity of induced contact eczema. A preparation contain-
ing 1.4% CpG-1-PTO showed no significant effects reflecting
the weaker in vitro efficacy. Recently, Akiba et al. (2004)
demonstrated in this journal that subcutaneous injection of
CpG-ODN induced a contact hypersensitivity response in
mice indicating that the observed effects are specific to the
route of application. A systemic or subcutaneous application
of ODN evokes a strong immune response accompanied with
the release of different cytokines, including TNFa, IL-6, and
IL-8 (Marshall et al., 2005). This effect is probably mediated
by CpG binding to TLR-9 expressed on immune cells. Topical
application of ODN onto intact skin seems to induce
tolerance and immune suppression preventing exaggerated
inflammation, maybe owing to the ubiquitous presence of
microbial and innate DNA on the integument.
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Figure 6. Non-CpG-5-PTO reduces ear swelling response and neutrophil infiltrate in DNFB-sensitized mice. Mice were sensitized with DNFB on day 0 and
re-exposed on day 5, respectively. In the ‘‘treatment group,’’ vehicle (DAC base cream), CpG-1-PTO, Non-CpG-5-PTO, or prednicarbate were applied to the
ear 60 minutes after re-exposition. The contralateral ear was treated with vehicle alone. (a) After 24 hours, ear swelling response was measured. Ear swelling
response is significantly reduced by Dermatops (prednicarbate) and also by Non-CpG-5-PTO-containing ointment, compared to base cream-treated mice.
CpG-1-PTO-treated mice show only a non-significant trend. Results are expressed as the mean ear swelling. P indicates statistical significance compared to base
cream treatment. (b) Twenty-four hours after re-exposition, ears were obtained for histological analysis (hematoxylin and eosin staining). Ears treated with
base cream show an increased dermal edema compared to prednicarbate-treated ears. Ears treated with Non-CpG-5-PTO show a reduced dermal edema
similar to prednicarbate-treated ears, whereas a treatment with CpG-1-PTO show edema comparable to ears treated with base cream. Results shown are
representative for four experiments (consisting of 12 mice per group). Bar¼100 mm. (c) Twenty-four hours after re-exposition, ears were obtained for histological
analysis of neutrophil infiltration. Sections show reduced neutrophil infiltration (blue cells) after treatment with Dermatops (prednicarbate) and
Non-CpG-5-PTO. CpG-1-PTO-treatment offered no effect. Results shown are representative for three experiments per group. Bar¼ 100mm. (d) Uptake of
topically applied Cy3-labeled CpG-1-PTO and Non-CpG-5-PTO (100 mm) onto shaved mouse skin specimen after 2 hours. ODN are within the epidermis as
well as in the supra-epidermal tissue. Bar¼ 50mm.
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MATERIALS AND METHODS
Oligodeoxynucleotides
ODN were synthesized and purified by BioSpring GmbH (Frankfurt/
Main, Germany), reconstituted in sterile pyrogen-free water, and
stored at 201C. For experiments, ODN were given directly to the
medium. In order to trace uptake and penetration, ODN were
50-fluorescent-labeled with Cy3. The ODN sequences used in this
study are listed in Table 1.
Cell culture
Spontaneously immortalized human keratinocyte cell line (HaCaT)
(Boukamp et al., 1988) (a generous gift by Norbert Fusenig, German
Cancer Research Institute, Heidelberg, Germany) was cultured in
carbonate buffered Hank’s medium with 5% fetal calf serum, 0.35 g/l
glutamine (Invitrogen, Karlsruhe, Germany), and 1% penicillin-
streptomycin solution (Biochrom KG, Berlin, Germany) at 371C in
5% CO2 atmosphere. The medium was renewed twice a week. Cells
were stimulated with TNFa purchased from PeproTech (London,
UK). Cultures of normal human keratinocytes were initiated from
human foreskin as described (Stein et al., 1997) and cultured in
keratinocyte growth medium-2 (Promocell, Heidelberg, Germany).
All experiments were performed in agreement with the local ethics
commission.
Hybridization and methylation of CpG-1-ODN
Equimolar amounts of CpG-1-PTO and CpG-1-PTO reverse were
hybridized (951C, 5 minutes; slowly cooled down). Methylation of
cytosine residues of hybridized strands was achieved using M. SssI
CpG methylase and S-adenosylmethionin (New England Biolabs,
Frankfurt, Germany) as methyl donor, according to the manufac-
turers’ instructions. Briefly, double strands (CpG-1-PTO/CpG-1-PTO
reverse) were incubated at 371C for 16 hours together with 10 U/ml
M. SssI CpG methylase and 160 mM S-adenosylmethionin in water
followed by enzyme inactivation at 651C for 30 minutes. Methyl-
ation was controlled using HpaII (New England Biolabs), a restriction
enzyme specific for methylated CpG motifs (10 U/ml HpaII, 371C,
16 hours). Sample degradation was controlled by polyacrylamide gel
electrophoresis (data not shown).
Plasmids and transfection
The human dominant-negative TLR-9 plasmid was kindly provided
by Hermann Wagner, Technische Universita¨t Mu¨nchen (Mu¨nchen,
Germany) (Bauer et al., 2001). The dominant-negative flag-tagged
MyD88 was kindly provided from Tularik (San Francisco, CA) (Bauer
et al., 2001). Empty pcDNA-3 served as control vector. Transient
transfection was performed using HaCaT cells plated in six-well
multidishes at a confluence of 70% using Lipofectamine 2000
reagent (Invitrogen) according to the manufacturers’ instructions.
The following day, cells were treated with CpG-1-PTO or Non-CpG-
5-PTO as described in ‘‘oligodeoxynucleotides’’ overnight and
cell-free supernatants were assayed for IL-8 expression (see below).
In parallel, TLR-9 (TLR-9 antibody, Imgenex, San Diego, CA)
and MyD88 overexpression (anti-Flag, Sigma-Aldrich, Mu¨nchen,
Germany) were detected by Western blot analysis in order to
monitor transfection efficacy (data not shown).
Quantitative real-time reverse transcription-PCR
Subconfluent cell cultures were treated with 4 mM ODN for 10 hours
either in the absence or presence of TNFa (50 ng/ml). After extraction
of total RNA (RNeasys Mini Kit, Qiagen, Hilden, Germany), reverse
transcription was performed using the Omniscripts RT Kit (Qiagen)
according to the manufacturers’ protocol. Real-time PCR was
Table 1. List of ODN used
Name Sequence
CpG-1-PTO 50-TCC ATG ACG TTC CTG ACG TT-30 (20-mer)
CpG-1-PDE 50-tcc atg acg ttc ctg acg tt-30 (20-mer)
CpG-17-PTO 5’-TCC ATG ACG TTC CTG ACG T-3’ (19-mer)
CpG-16-PTO 5’-TCC ATG ACG TTC CTG ACG-3’ (18-mer)
CpG-14-PTO 5’-TCC TCG ACG TCC CTG A-3’ (16-mer)
CpG-12-PTO 5’-CAT GAC GTT CCT-3’ (12-mer)
CpG-9-PTO 5’-GAC GTT-3’ (6-mer)
CpG-1-PTO reverse 5’-AAC GTC AGG AAC GTC ATG GA-3’ (20-mer)
Non-CpG-5-PTO 5’-CCC CCC CCC CCC CCC CCC CC-3’ (20-mer)
Non-CpG-5A-PTO 5’-CCC CCC CCC CCC CCC CCC-3’ (18-mer)
Non-CpG-5B-PTO 5’-CCC CCC CCC CCC CCC C-3’ (16-mer)
Non-CpG-5C-PTO 5’-CCC CCC CCC CCC CC-3’ (14-mer)
Non-CpG-5D-PTO 5’-CCC CCC CCC CCC-3’ (12-mer)
Non-CpG-5G-PTO 5’-CCC CCC-3’ (6-mer)
CpG, cytidine-phosphate-guanosine; PDE, phosphodiester; ODN, oligodeoxynucleotides.
Capital letters represent PTO bondings, small letters represent PDE bondings.
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performed using the Bio-Rad iQ iCycler Detection System
(Bio-Rad Laboratories, Mu¨nchen, Germany) with SYBR
green as fluorophore. Reactions were performed in a total volume
of 30 ml, including 0.3 ml cDNA, 15 ml 2 SYBR Green PCR
Master Mix (Bio-Rad), and 0.5 mM primers for IL-8 or glyceralde-
hyde-3-phosphate dehydrogenase as housekeeping control.
Primer sequences are published by Kippenberger et al. (2001).
Reactions started with an initial heating step at 941C for 3 minutes
followed by 40 PCR cycles: 941C (45 seconds), 581C (30 seconds),
and 721C (45 seconds). Reactions were terminated by performing
a melting curve analysis using the iCycler iQTM Real-Time
Detection System software (Bio-Rad). The delta-delta CT method
was applied for the relative quantification of the IL-8 expression
using GAPDH expression as control. All reactions were carried out
as triplicates.
ELISA of IL-8
Cells were exposed for 18 hours to different ODN, either in the
absence or presence of 20 ng/ml TNFa. Cell-free supernatants were
obtained and assayed for human IL-8 using a commercial ELISA test
kit (Bender Med Systems, Vienna, Austria) according to the
manufacturers’ instructions. Briefly, supernatants were placed in
microwell plates coated with antibodies against IL-8. After incuba-
tion with horseradish-peroxidase conjugate, tetramethylbenzidine
(Sigma-Aldrich) was added giving rise to a colored product measured
at 450 nm in a scanning multiwell spectrophotometer (ELISA reader
MR 5000, Dynatech, Guernsey, UK). The lower limit of detection for
the IL-8-ELISA was 10 pg/ml.
DNA synthesis
Cells were seeded in microwell plates at a density of 2 104 cells/
well (0.33 cm2/well), serum-starved for 24 hours, and then exposed
for 18 hours to different ODN at the indicated concentrations in
medium without fetal calf serum. Cells grown in the presence of 5%
fetal calf serum served as positive control. For the last 18 hours, cells
were pulsed with 5-bromodeoxyuridine. Subsequently, the incor-
poration rate of 5-bromodeoxyuridine was determined using a
commercial ELISA kit (Roche, Grenzach-Whylen, Germany). Briefly,
cells were fixed and immune complexes were formed using per-
oxidase-coupled 5-bromodeoxyuridine antibodies. A colorimetric
reaction with tetramethylbenzidine as a substrate gave rise to a
reaction product measured at 450 nm in a multiwell spectrophotometer
(ELISA reader).
Cytotoxicity
Cell lysis was quantified using the cytotoxicity detection kit (Roche),
which is based on release of LDH from damaged cells. Briefly, cells
were seeded out in microwell plates as aforementioned and treated
with the different ODN for 18 hours. In a first step, cell-free
supernatants were incubated with NADþ , which becomes reduced
by LDH to NADH/Hþ . In the second step, NADH/Hþ reduces a
yellow tetrazolium salt to a red-colored formazan salt. The amount
of red color is proportional to the number of lysed cells. For
quantitation, the absorbance of the reaction product was measured
at 490 nm using a multiwell spectrophotometer (ELISA reader). Cells
treated with 1% Triton X-100 (Merck, Darmstadt, Germany) served
as positive control.
Cellular uptake and skin penetration of ODN
Uptake of ODN into cells was observed in HaCaT keratinocytes
seeded in chambered glass slides (LabTek, Nunc, Wiesbaden,
Germany) at a density of 8 105 cells/well (1.8 cm2/well). After
18 hours, cells were washed with phosphate-buffered saline and
incubated for 1 minute with 1 mM 50-Cy3-labeled CpG-1-PTO, CpG-
9-PTO, Non-CpG-5-PTO, or Non-CpG-5G-PTO in Hank’s medium.
Then, ODN were washed off and fresh medium was added. After
different incubation intervals (5, 10, 60 minutes, 18 hours) and
another washing step, cells were fixed using 95% ethanol and 5%
acetic acid (10 minutes, room temperature). After a washing step, the
nuclei were stained with SytoxGreen (1:10,000 in phosphate-
buffered saline, 20 minutes, room temperature; Invitrogen). Finally,
slides were mounted in Aquatex (Merck) and examined on a con-
focal laser scanning microscope (TCS, Leica, Bensheim, Germany).
In order to study skin penetration, Cy3-labeled ODN solved in water
(100mM) were topically applied onto shaved mouse back skin
specimen. Samples were fixed in 4.5% formalin and embedded
in paraffin. Thin sections were analyzed by using fluorescent
microscopy.
Induction of a murine allergic contact dermatitis reaction and
immunohistochemistry
Male C57BL/6 mice, aged 6–10 weeks were purchased from Charles
River (Sulzfeld, Germany) and housed with food and water ad lib.
Animal experiments have been approved by the governmental
administration of Hessen (Darmstadt, Germany). An allergic contact
dermatitis (contact hypersensitivity) was elicited using DNFB
according to standard protocols (Schwarz et al., 2000; Ludwig
et al., 2005). In brief, mice were sensitized by applying 75 ml of
0.5% DNFB (Sigma-Aldrich) solution (4:1 acetone/olive oil, vol/vol)
on the back on day 0. On day 5, 10 ml of 0.3% DNFB were applied
on the left and right ear for re-exposition. After 60 minutes, vehicle,
1.4% CpG-1-PTO- or Non-CpG-5-PTO-containing ointment, or
prednicarbate (Dermatops, 0.25%, Sanofi-Aventis, Frankfurt/Main,
Germany) were applied to one re-exposed ear. Base cream (DAC)
devoid of active components was used as negative control. The contra-
lateral ear was treated with vehicle alone. Twenty-four hours after re-
exposition, contact hypersensitivity response was determined using a
spring-loaded micrometer (Mitutoyo, Neuss, Germany) and ears
were obtained for analysis. Specimen were fixed in 4.5%
formalin, embedded in paraffin, and stained with hematoxylin and
eosin. Ear swelling responses of DNFB-challenged ears were
compared to the response of the vehicle-treated ear in sensitized
animals and were expressed as centimeters 103 (mean7SD).
Neutrophil infiltration was assessed by staining paraffin-embedded
specimen with a rat anti-mouse neutrophil antibody (clone 7/4,
Serotec, Oxford, UK). Before application of primary antibody,
sections were subjected to heat for 40 minutes at 951C. Neutrophils
were visualized using the Histo Green Kit (Linaris, Wertheim,
Germany) as described in detail elsewhere (Ludwig et al., 2005).
Negative controls were obtained by omission of primary antibody.
Statistical analysis
Statistical analysis was performed using the Mann–Whitney U–test of
SalStats (Boston, MA). The methods used for evaluation of statistical
significance are indicated in the figure legends.
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